首页> 美国卫生研究院文献>BMC Bioinformatics >Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models
【2h】

Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models

机译:癌症预后预测使用躯体点突变和拷贝数变异数据:基于基于基于途径和途径的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Workflow of gene-level models. In the 5 boxes are 5 intersected sets we achieved after filtering. “All” represents all the genes in the data, “Path” represents all the genes in the pathway collection, “COSM” represents all the genes in the COSMIC database, “Cox” represents all the genes which have significant p value in the univariable Cox model. The gene subsets represented by the 2 boxes after the dashed arrows were only applied to SPM data. 5-fold cross validation is conducted and for each training set, Cox Lasso is fitted. The estimated Cox model is applied to the test set to assess predictive performance. Unpenalized Cox models are also fitted, with the average value of lambda as the regularization parameter, to obtain non-shrunken coefficient estimates and p values
机译:基因级模型的工作流程。在5个盒子中,我们在过滤后实现了5个相交的集合。 “全部”代表数据中的所有基因,“路径”代表途径收集中的所有基因,“COSM”代表宇宙数据库中的所有基因,“COX”代表在单变度中具有显着的P值的所有基因COX模型。在虚线箭头后由2个盒子表示的基因子集仅应用于SPM数据。进行5倍交叉验证,并针对每个训练套,安装了Cox套索。估计的Cox模型应用于测试集以评估预测性能。未经缩减的Cox模型也适用于Lambda作为正则化参数的平均值,以获得非缩小系数估计和P值

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号